Improving Lives Through Nuclear Medicine™



MAA Pricing: FAQ

Each year, more than three million patients in North America find themselves up against a deadly foe – pulmonary embolism (PE) – and without early detection and diagnosis; many patients will lose their lives. However, Lung Ventilation and Perfusion (V/Q) scanning, an advanced imaging procedure, has proven to be essential to overcoming this perilous condition. Through V/Q scans, physicians can swiftly and accurately detect and treat suspected cases of PE with the most appropriate remedies, or withhold unnecessary treatment if PE is ruled out. The availability of V/Q scanning facilitates timely care that alleviates patient suffering, and helps to reduce instances of PE-related death.

Jubilant DraxImage recognizes that every life is a precious one. We also believe it is our great responsibility to preserve the nuclear medicine community’s ongoing access to the critical radiopharmaceuticals needed for V/Q scans so that hospitals, healthcare organizations, and physicians can continue to deliver the highest quality of patient care possible.

We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness
of campaigns and analyze traffic. If you continue to use this site we will assume your acceptance.